Ketotifen for kids with stomach pain and duodenal eosinophilia
Treatments studied
Part of Blood & lymphatic clinical trials.
This study tests whether ketotifen can improve long-lasting stomach pain in children whose biopsies show high levels of a certain immune cell type in the small intestine. It may help if standard stomach-acid medicines and montelukast did not work well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 8 to 17 years old
- You have belly pain that has lasted at least 8 weeks and fits functional dyspepsia symptoms
- A prior endoscopy with stomach/small-intestine biopsies showed more than 20 eosinophils per high-power field in the duodenum
- You previously tried acid-reduction medicine and montelukast, but they helped only a little (level 3 response or less)
- You have not taken ketotifen before
- If you could become pregnant: you agree to a pregnancy test and use effective birth control if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called budesonide can help people with a type of chronic stomach discomfort that gets worse after meals (functional dyspepsia). If you often feel full or bloated after eating and have had a normal stomach exam, this study may be a good fit for you.
This trial tests whether cognitive behavioral therapy (CBT) — a type of talk therapy that helps change thoughts and behaviors — can ease the stomach pain and discomfort of functional dyspepsia. You'll also provide samples for research, which may help understand how this condition works.
This trial tests if dupilumab can help young children with eosinophilic esophagitis (EoE), a condition that causes swelling in the esophagus. It may reduce symptoms and improve how the esophagus heals.
This trial tests new ways to ease the stomach pain, bloating, or burning that comes with functional dyspepsia—a condition where your stomach feels upset but tests like an endoscopy look normal. The treatment aims to help your gut, liver, and brain work together better, which may reduce your symptoms.
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
This study compares two treatments for EoE that has caused narrowing in the esophagus: dupilumab (a biologic injection) versus a topical corticosteroid (a swallowed steroid). It aims to see which works better for teens and young adults to improve swallowing and reduce inflammation.
Hear when a new Functional Dyspepsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.